Using a vena cava filter to prevent pulmonary embolism
Study of ALN's OATF Vena Cava Filter
Assistance Publique - Hôpitaux de Paris · NCT05785676
This study is testing whether a special filter can help prevent blood clots in patients at risk for pulmonary embolism who can't take blood thinners.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris (other) |
| Locations | 1 site (Paris, Ile-de-France) |
| Trial ID | NCT05785676 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the implantation of the ALN OATF vena cava filter (VCF) in patients at risk of pulmonary embolism (PE) who cannot use anticoagulation therapy. It aims to document the rates of filter implantation, removal, and any complications that arise during its use in clinical practice. The study will involve patients who have been informed and consented to participate, ensuring ethical standards are maintained. Data will be collected from patients implanted with the filter at a designated medical center in Paris.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with acute pulmonary embolism or deep vein thrombosis who cannot receive anticoagulation therapy.
Not a fit: Patients who are minors, pregnant, or under legal protection measures will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management of patients at risk for pulmonary embolism by providing insights into the safety and efficacy of the ALN OATF vena cava filter.
How similar studies have performed: Other studies have explored the use of vena cava filters, but the specific application of the ALN OATF filter in this context is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient implanted with an ALN OATF VCF * Patient informed Exclusion Criteria: * Minor patient * Adult patient under a legal protection measure * Pregnant, parturient or breastfeeding women * Patient who refused to participate * Patient who cannot or does not wish to be followed by the Interventional Radiology Department
Where this trial is running
Paris, Ile-de-France
- AP-HP - Hôpital Européen Georges-Pompidou Paris, France — Paris, Ile-de-France, France (RECRUITING)
Study contacts
- Principal investigator: Olivier PELLERIN, MD - PhD — Assistance Publique - Hôpitaux de Paris
- Study coordinator: Breno MELO, PhD
- Email: gestion-locale.drc@aphp.fr
- Phone: +33140271840
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pulmonary Embolism, Vena Cava Filter